Thermo Fisher Scientific Inc.TMONYSE
LOADING
|||
Operating cash flow minus capital expenditures
| Period | Value | Change |
|---|---|---|
| 2024 | $7.27B | +4.9% |
| 2023 | $6.93B | +0.2% |
| 2022 | $6.91B | -1.6% |
| 2021 | $7.02B | +3.0% |
| 2020 | $6.82B | +68.4% |
| 2019 | $4.05B | +6.9% |
| 2018 | $3.79B | +8.2% |
| 2017 | $3.50B | +29.0% |
| 2016 | $2.71B | +13.3% |
| 2015 | $2.39B | - |